CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 106 filers reported holding CYMABAY THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $589,169 | +56.1% | 39,515 | +14.7% | 0.00% | – |
| Q2 2023 | $377,392 | +95.2% | 34,465 | +55.5% | 0.00% | – |
| Q1 2023 | $193,314 | +7.1% | 22,169 | -23.0% | 0.00% | – |
| Q4 2022 | $180,457 | -1.4% | 28,781 | -44.8% | 0.00% | – |
| Q3 2022 | $183,000 | -30.2% | 52,185 | -41.2% | 0.00% | – |
| Q2 2022 | $262,000 | -13.8% | 88,712 | -9.1% | 0.00% | – |
| Q1 2022 | $304,000 | +16.5% | 97,604 | +26.3% | 0.00% | – |
| Q4 2021 | $261,000 | -13.9% | 77,267 | -7.0% | 0.00% | – |
| Q3 2021 | $303,000 | -30.2% | 83,058 | -16.6% | 0.00% | – |
| Q2 2021 | $434,000 | -6.1% | 99,565 | -2.1% | 0.00% | – |
| Q1 2021 | $462,000 | +62.7% | 101,676 | +105.7% | 0.00% | – |
| Q4 2020 | $284,000 | +40.6% | 49,434 | +76.8% | 0.00% | – |
| Q3 2020 | $202,000 | +818.2% | 27,957 | +152.8% | 0.00% | – |
| Q4 2019 | $22,000 | -91.2% | 11,059 | -77.2% | 0.00% | – |
| Q3 2019 | $249,000 | -36.0% | 48,590 | -10.5% | 0.00% | -100.0% |
| Q2 2019 | $389,000 | -43.1% | 54,293 | +5.4% | 0.00% | 0.0% |
| Q1 2019 | $684,000 | +5.7% | 51,513 | -37.3% | 0.00% | 0.0% |
| Q4 2018 | $647,000 | -23.4% | 82,205 | +7.7% | 0.00% | 0.0% |
| Q3 2018 | $845,000 | +48.5% | 76,306 | +80.0% | 0.00% | 0.0% |
| Q2 2018 | $569,000 | +3.6% | 42,399 | +0.4% | 0.00% | 0.0% |
| Q1 2018 | $549,000 | +12.3% | 42,230 | -20.5% | 0.00% | 0.0% |
| Q4 2017 | $489,000 | +71.6% | 53,148 | +50.6% | 0.00% | 0.0% |
| Q3 2017 | $285,000 | – | 35,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 1,787,094 | $26,645,572 | 14.80% |
| Lynx1 Capital Management LP | 994,161 | $14,822,941 | 9.80% |
| Octagon Capital Advisors LP | 3,073,750 | $45,829,613 | 7.04% |
| Saturn V Capital Management LP | 1,124,459 | $16,765,684 | 7.02% |
| Altium Capital Management LP | 800,000 | $11,928,000 | 6.22% |
| Affinity Asset Advisors, LLC | 1,129,376 | $16,838,996 | 4.74% |
| ACUTA CAPITAL PARTNERS, LLC | 418,000 | $6,232,380 | 4.18% |
| Cormorant Asset Management, LP | 3,850,000 | $57,403,500 | 3.35% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 590,000 | $8,796,900 | 2.67% |
| MPM BioImpact LLC | 610,770 | $9,106,581 | 2.43% |